중동 및 아프리카 동물 및 인간 백신 시장 – 2031년까지의 산업 동향 및 예측

TABLE 1 VACCINES UNDER CLINICAL TRIAL

TABLE 2 THE SIDE EFFECTS RELATED TO VACCINES

TABLE 3 MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET, BY TYPE 2022-2031 (USD THOUSAND)

TABLE 4 MIDDLE EAST AND AFRICA HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 5 MIDDLE EAST AND AFRICA HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 6 MIDDLE EAST AND AFRICA ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 7 MIDDLE EAST AND AFRICA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 8 MIDDLE EAST AND AFRICA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 9 MIDDLE EAST AND AFRICA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 10 MIDDLE EAST AND AFRICA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

THE AFRICAN HORSE SICKNESS SEGMENT IS FURTHER SUB-SEGMENTED BY TYPE INTO LIVE AND INACTIVATED. 92

TABLE 11 MIDDLE EAST AND AFRICA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 12 MIDDLE EAST AND AFRICA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 13 MIDDLE EAST AND AFRICA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 14 MIDDLE EAST AND AFRICA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 15 MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 16 MIDDLE EAST AND AFRICA HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 17 MIDDLE EAST AND AFRICA CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 18 MIDDLE EAST AND AFRICA OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 19 MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 20 MIDDLE EAST ANIMAL AND HUMAN VACCINES MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)

TABLE 21 MIDDLE EAST ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 22 MIDDLE EAST HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 23 MIDDLE EAST HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 24 MIDDLE EAST ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 25 MIDDLE EAST BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 26 MIDDLE EAST BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 27 MIDDLE EAST FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 28 MIDDLE EAST FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 29 MIDDLE EAST AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 30 MIDDLE EAST AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 31 MIDDLE EAST RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 32 MIDDLE EAST RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 33 MIDDLE EAST ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 34 MIDDLE EAST HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 35 MIDDLE EAST CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 36 MIDDLE EAST OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 37 MIDDLE EAST ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 38 SAUDI ARABIA ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 39 SAUDI ARABIA HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 40 SAUDI ARABIA HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 41 SAUDI ARABIA ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 42 SAUDI ARABIA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 43 SAUDI ARABIA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 44 SAUDI ARABIA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 45 SAUDI ARABIA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 46 SAUDI ARABIA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 47 SAUDI ARABIA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 48 SAUDI ARABIA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 49 SAUDI ARABIA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 50 SAUDI ARABIA ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 51 SAUDI ARABIA HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 52 SAUDI ARABIA CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 53 SAUDI ARABIA OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 54 SAUDI ARABIA ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 55 EGYPT ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 56 EGYPT HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 57 EGYPT HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 58 EGYPT ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 59 EGYPT BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 60 EGYPT BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 61 EGYPT FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 62 EGYPT FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 63 EGYPT AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 64 EGYPT AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 65 EGYPT RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 66 EGYPT RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 67 EGYPT ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 68 EGYPT HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 69 EGYPT CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 70 EGYPT OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 71 EGYPT ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 72 U.A.E. ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 73 U.A.E. HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 74 U.A.E. HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 75 U.A.E. ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 76 U.A.E. BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 77 U.A.E. BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 78 U.A.E. FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 79 U.A.E. FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 80 U.A.E. AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 81 U.A.E. AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 82 U.A.E. RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 83 U.A.E. RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 84 U.A.E. ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 85 U.A.E. HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 86 U.A.E. CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 87 U.A.E. OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 88 U.A.E. ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 89 ISRAEL ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 90 ISRAEL HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 91 ISRAEL HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 92 ISRAEL ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 93 ISRAEL BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 94 ISRAEL BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 95 ISRAEL FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 96 ISRAEL FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 97 ISRAEL AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 98 ISRAEL AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 99 ISRAEL RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 100 ISRAEL RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 101 ISRAEL ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 102 ISRAEL HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 103 ISRAEL CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 104 ISRAEL OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 105 ISRAEL ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 106 IRAN ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 107 IRAN HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 108 IRAN HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 109 IRAN ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 110 IRAN BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 111 IRAN BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 112 IRAN FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 113 IRAN FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 114 IRAN AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 115 IRAN AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 116 IRAN RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 117 IRAN RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 118 IRAN ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 119 IRAN HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 120 IRAN CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 121 IRAN OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 122 IRAN ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 123 IRAQ ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 124 IRAQ HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 125 IRAQ HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 126 IRAQ ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 127 IRAQ BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 128 IRAQ BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 129 IRAQ FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 130 IRAQ FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 131 IRAQ AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 132 IRAQ AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 133 IRAQ RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 134 IRAQ RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 135 IRAQ ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 136 IRAQ HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 137 IRAQ CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 138 IRAQ OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 139 IRAQ ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 140 OMAN ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 141 OMAN HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 142 OMAN HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 143 OMAN ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 144 OMAN BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 145 OMAN BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 146 OMAN FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 147 OMAN FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 148 OMAN AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 149 OMAN AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 150 OMAN RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 151 OMAN RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 152 OMAN ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 153 OMAN HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 154 OMAN CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 155 OMAN OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 156 OMAN ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 157 KUWAIT ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 158 KUWAIT HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 159 KUWAIT HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 160 KUWAIT ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 161 KUWAIT BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 162 KUWAIT BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 163 KUWAIT FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 164 KUWAIT FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 165 KUWAIT AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 166 KUWAIT AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 167 KUWAIT RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 168 KUWAIT RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 169 KUWAIT ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 170 KUWAIT HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 171 KUWAIT CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 172 KUWAIT OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 173 KUWAIT ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 174 QATAR ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 175 QATAR HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 176 QATAR HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 177 QATAR ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 178 QATAR BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 179 QATAR BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 180 QATAR FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 181 QATAR FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 182 QATAR AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 183 QATAR AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 184 QATAR RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 185 QATAR RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 186 QATAR ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 187 QATAR HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 188 QATAR CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 189 QATAR OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 190 QATAR ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 191 BAHRAIN ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 192 BAHRAIN HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 193 BAHRAIN HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 194 BAHRAIN ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 195 BAHRAIN BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 196 BAHRAIN BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 197 BAHRAIN FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 198 BAHRAIN FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 199 BAHRAIN AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 200 BAHRAIN AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 201 BAHRAIN RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 202 BAHRAIN RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 203 BAHRAIN ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 204 BAHRAIN HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 205 BAHRAIN CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 206 BAHRAIN OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 207 BAHRAIN ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 208 YEMEN ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 209 YEMEN HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 210 YEMEN HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 211 YEMEN ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 212 YEMEN BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 213 YEMEN BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 214 YEMEN FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 215 YEMEN FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 216 YEMEN AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 217 YEMEN AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 218 YEMEN RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 219 YEMEN RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 220 YEMEN ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 221 YEMEN HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 222 YEMEN CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 223 YEMEN OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 224 YEMEN ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 225 JORDAN ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 226 JORDAN HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 227 JORDAN HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 228 JORDAN ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 229 JORDAN BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 230 JORDAN BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 231 JORDAN FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 232 JORDAN FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 233 JORDAN AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 234 JORDAN AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 235 JORDAN RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 236 JORDAN RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 237 JORDAN ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 238 JORDAN HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 239 JORDAN CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 240 JORDAN OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 241 JORDAN ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 242 LEBANON ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 243 LEBANON HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 244 LEBANON HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 245 LEBANON ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 246 LEBANON BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 247 LEBANON BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 248 LEBANON FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 249 LEBANON FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 250 LEBANON AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 251 LEBANON AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 252 LEBANON RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 253 LEBANON RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 254 LEBANON ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 255 LEBANON HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 256 LEBANON CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 257 LEBANON OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 258 LEBANON ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 259 PALESTINE ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 260 PALESTINE HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 261 PALESTINE HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 262 PALESTINE ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 263 PALESTINE BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 264 PALESTINE BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 265 PALESTINE FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 266 PALESTINE FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 267 PALESTINE AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 268 PALESTINE AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 269 PALESTINE RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 270 PALESTINE RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 271 PALESTINE ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 272 PALESTINE HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 273 PALESTINE CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 274 PALESTINE OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 275 PALESTINE ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 276 REST OF MIDDLE EAST ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 277 AFRICA ANIMAL AND HUMAN VACCINES MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)

TABLE 278 AFRICA ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 279 AFRICA HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 280 AFRICA HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 281 AFRICA ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 282 AFRICA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 283 AFRICA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 284 AFRICA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 285 AFRICA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 286 AFRICA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 287 AFRICA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 288 AFRICA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 289 AFRICA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 290 AFRICA ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 291 AFRICA HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 292 AFRICA CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 293 AFRICA OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 294 AFRICA ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 295 SOUTH AFRICA ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 296 SOUTH AFRICA HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 297 SOUTH AFRICA HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 298 SOUTH AFRICA ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 299 SOUTH AFRICA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 300 SOUTH AFRICA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 301 SOUTH AFRICA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 302 SOUTH AFRICA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 303 SOUTH AFRICA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 304 SOUTH AFRICA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 305 SOUTH AFRICA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 306 SOUTH AFRICA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 307 SOUTH AFRICA ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 308 SOUTH AFRICA HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 309 SOUTH AFRICA CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 310 SOUTH AFRICA OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 311 SOUTH AFRICA ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 312 NIGERIA ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 313 NIGERIA HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 314 NIGERIA HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 315 NIGERIA ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 316 NIGERIA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 317 NIGERIA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 318 NIGERIA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 319 NIGERIA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 320 NIGERIA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 321 NIGERIA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 322 NIGERIA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 323 NIGERIA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 324 NIGERIA ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 325 NIGERIA HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 326 NIGERIA CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 327 NIGERIA OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 328 NIGERIA ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 329 ETHIOPIA ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 330 ETHIOPIA HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 331 ETHIOPIA HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 332 ETHIOPIA ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 333 ETHIOPIA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 334 ETHIOPIA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 335 ETHIOPIA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 336 ETHIOPIA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 337 ETHIOPIA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 338 ETHIOPIA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 339 ETHIOPIA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 340 ETHIOPIA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 341 ETHIOPIA ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 342 ETHIOPIA HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 343 ETHIOPIA CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 344 ETHIOPIA OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 345 ETHIOPIA ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 346 TANZANIA ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 347 TANZANIA HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 348 TANZANIA HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 349 TANZANIA ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 350 TANZANIA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 351 TANZANIA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 352 TANZANIA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 353 TANZANIA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 354 TANZANIA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 355 TANZANIA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 356 TANZANIA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 357 TANZANIA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 358 TANZANIA ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 359 TANZANIA HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 360 TANZANIA CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 361 TANZANIA OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 362 TANZANIA ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 363 KENYA ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 364 KENYA HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 365 KENYA HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 366 KENYA ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 367 KENYA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 368 KENYA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 369 KENYA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 370 KENYA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 371 KENYA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 372 KENYA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 373 KENYA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 374 KENYA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 375 KENYA ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 376 KENYA HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 377 KENYA CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 378 KENYA OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 379 KENYA ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 380 ALGERIA ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 381 ALGERIA HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 382 ALGERIA HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 383 ALGERIA ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 384 ALGERIA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 385 ALGERIA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 386 ALGERIA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 387 ALGERIA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 388 ALGERIA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 389 ALGERIA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 390 ALGERIA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 391 ALGERIA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 392 ALGERIA ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 393 ALGERIA HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 394 ALGERIA CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 395 ALGERIA OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 396 ALGERIA ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 397 GHANA ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 398 GHANA HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 399 GHANA HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 400 GHANA ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 401 GHANA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 402 GHANA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 403 GHANA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 404 GHANA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 405 GHANA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 406 GHANA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 407 GHANA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 408 GHANA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 409 GHANA ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 410 GHANA HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 411 GHANA CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 412 GHANA OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 413 GHANA ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 414 MOZAMBIQUE ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 415 MOZAMBIQUE HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 416 MOZAMBIQUE HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 417 MOZAMBIQUE ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 418 MOZAMBIQUE BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 419 MOZAMBIQUE BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 420 MOZAMBIQUE FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 421 MOZAMBIQUE FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 422 MOZAMBIQUE AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 423 MOZAMBIQUE AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 424 MOZAMBIQUE RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 425 MOZAMBIQUE RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 426 MOZAMBIQUE ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 427 MOZAMBIQUE HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 428 MOZAMBIQUE CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 429 MOZAMBIQUE OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 430 MOZAMBIQUE ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 431 UGANDA ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 432 UGANDA HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 433 UGANDA HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 434 UGANDA ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 435 UGANDA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 436 UGANDA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 437 UGANDA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 438 UGANDA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 439 UGANDA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 440 UGANDA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 441 UGANDA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 442 UGANDA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 443 UGANDA ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 444 UGANDA HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 445 UGANDA CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 446 UGANDA OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 447 UGANDA ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 448 DEMOCRATIC REPUBLIC OF CONGO ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 449 DEMOCRATIC REPUBLIC OF CONGO HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 450 DEMOCRATIC REPUBLIC OF CONGO HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 451 DEMOCRATIC REPUBLIC OF CONGO ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 452 DEMOCRATIC REPUBLIC OF CONGO BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 453 DEMOCRATIC REPUBLIC OF CONGO BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 454 DEMOCRATIC REPUBLIC OF CONGO FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 455 DEMOCRATIC REPUBLIC OF CONGO FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 456 DEMOCRATIC REPUBLIC OF CONGO AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 457 DEMOCRATIC REPUBLIC OF CONGO AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 458 DEMOCRATIC REPUBLIC OF CONGO RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 459 DEMOCRATIC REPUBLIC OF CONGO RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 460 DEMOCRATIC REPUBLIC OF CONGO ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 461 DEMOCRATIC REPUBLIC OF CONGO HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 462 DEMOCRATIC REPUBLIC OF CONGO CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 463 DEMOCRATIC REPUBLIC OF CONGO OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 464 DEMOCRATIC REPUBLIC OF CONGO ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 465 SUDAN ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 466 SUDAN HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 467 SUDAN HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 468 SUDAN ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 469 SUDAN BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 470 SUDAN BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 471 SUDAN FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 472 SUDAN FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 473 SUDAN AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 474 SUDAN AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 475 SUDAN RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 476 SUDAN RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 477 SUDAN ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 478 SUDAN HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 479 SUDAN CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 480 SUDAN OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 481 SUDAN ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 482 MOROCCO ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 483 MOROCCO HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 484 MOROCCO HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 485 MOROCCO ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 486 MOROCCO BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 487 MOROCCO BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 488 MOROCCO FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 489 MOROCCO FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 490 MOROCCO AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 491 MOROCCO AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 492 MOROCCO RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 493 MOROCCO RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 494 MOROCCO ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 495 MOROCCO HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 496 MOROCCO CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 497 MOROCCO OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 498 MOROCCO ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 499 ANGOLA ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 500 ANGOLA HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 501 ANGOLA HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 502 ANGOLA ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 503 ANGOLA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 504 ANGOLA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 505 ANGOLA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 506 ANGOLA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 507 ANGOLA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 508 ANGOLA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 509 ANGOLA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 510 ANGOLA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 511 ANGOLA ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 512 ANGOLA HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 513 ANGOLA CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 514 ANGOLA OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 515 ANGOLA ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 516 MADAGASCAR ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 517 MADAGASCAR HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 518 MADAGASCAR HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 519 MADAGASCAR ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 520 MADAGASCAR BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 521 MADAGASCAR BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 522 MADAGASCAR FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 523 MADAGASCAR FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 524 MADAGASCAR AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 525 MADAGASCAR AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 526 MADAGASCAR RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 527 MADAGASCAR RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 528 MADAGASCAR ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 529 MADAGASCAR HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 530 MADAGASCAR CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 531 MADAGASCAR OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 532 MADAGASCAR ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 533 MALAWI ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 534 MALAWI HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 535 MALAWI HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 536 MALAWI ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 537 MALAWI BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 538 MALAWI BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 539 MALAWI FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 540 MALAWI FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 541 MALAWI AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 542 MALAWI AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 543 MALAWI RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 544 MALAWI RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 545 MALAWI ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 546 MALAWI HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 547 MALAWI CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 548 MALAWI OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 549 MALAWI ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 550 ZAMBIA ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 551 ZAMBIA HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 552 ZAMBIA HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 553 ZAMBIA ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 554 ZAMBIA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 555 ZAMBIA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 556 ZAMBIA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 557 ZAMBIA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 558 ZAMBIA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 559 ZAMBIA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 560 ZAMBIA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 561 ZAMBIA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 562 ZAMBIA ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 563 ZAMBIA HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 564 ZAMBIA CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 565 ZAMBIA OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 566 ZAMBIA ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 567 IVORY COAST ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 568 IVORY COAST HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 569 IVORY COAST HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 570 IVORY COAST ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 571 IVORY COAST BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 572 IVORY COAST BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 573 IVORY COAST FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 574 IVORY COAST FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 575 IVORY COAST AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 576 IVORY COAST AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 577 IVORY COAST RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 578 IVORY COAST RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 579 IVORY COAST ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 580 IVORY COAST HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 581 IVORY COAST CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 582 IVORY COAST OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 583 IVORY COAST ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 584 CAMEROON ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 585 CAMEROON HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 586 CAMEROON HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 587 CAMEROON ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 588 CAMEROON BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 589 CAMEROON BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 590 CAMEROON FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 591 CAMEROON FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 592 CAMEROON AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 593 CAMEROON AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 594 CAMEROON RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 595 CAMEROON RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 596 CAMEROON ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 597 CAMEROON HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 598 CAMEROON CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 599 CAMEROON OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 600 CAMEROON ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 601 ZIMBABWE ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 602 ZIMBABWE HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 603 ZIMBABWE HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 604 ZIMBABWE ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 605 ZIMBABWE BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 606 ZIMBABWE BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 607 ZIMBABWE FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 608 ZIMBABWE FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 609 ZIMBABWE AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 610 ZIMBABWE AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 611 ZIMBABWE RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 612 ZIMBABWE RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 613 ZIMBABWE ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 614 ZIMBABWE HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 615 ZIMBABWE CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 616 ZIMBABWE OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 617 ZIMBABWE ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 618 LIBYA ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 619 LIBYA HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 620 LIBYA HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 621 LIBYA ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 622 LIBYA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 623 LIBYA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 624 LIBYA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 625 LIBYA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 626 LIBYA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 627 LIBYA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 628 LIBYA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 629 LIBYA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 630 LIBYA ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 631 LIBYA HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 632 LIBYA CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 633 LIBYA CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 634 LIBYA ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 635 CHAD ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 636 CHAD HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 637 CHAD HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 638 CHAD ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 639 CHAD BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 640 CHAD BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 641 CHAD FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 642 CHAD FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 643 CHAD AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 644 CHAD AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 645 CHAD RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 646 CHAD RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 647 CHAD ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 648 CHAD HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 649 CHAD CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 650 CHAD OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 651 CHAD ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 652 BOTSWANA ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 653 BOTSWANA HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 654 BOTSWANA HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 655 BOTSWANA ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 656 BOTSWANA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 657 BOTSWANA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 658 BOTSWANA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 659 BOTSWANA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 660 BOTSWANA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 661 BOTSWANA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 662 BOTSWANA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 663 BOTSWANA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 664 BOTSWANA ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 665 BOTSWANA HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 666 BOTSWANA CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 667 BOTSWANA OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 668 BOTSWANA ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 669 NAMIBIA ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 670 NAMIBIA HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 671 NAMIBIA HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 672 NAMIBIA ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 673 NAMIBIA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 674 NAMIBIA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 675 NAMIBIA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 676 NAMIBIA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 677 NAMIBIA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 678 NAMIBIA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 679 NAMIBIA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 680 NAMIBIA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 681 NAMIBIA ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 682 NAMIBIA HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 683 NAMIBIA CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 684 NAMIBIA OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 685 NAMIBIA ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 686 LESOTHO ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 687 LESOTHO HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 688 LESOTHO HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 689 LESOTHO ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 690 LESOTHO BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 691 LESOTHO BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 692 LESOTHO FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 693 LESOTHO FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 694 LESOTHO AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 695 LESOTHO AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 696 LESOTHO RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 697 LESOTHO RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 698 LESOTHO ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 699 LESOTHO HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 700 LESOTHO CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 701 LESOTHO OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 702 LESOTHO ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 703 MAURITIUS ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 704 MAURITIUS HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 705 MAURITIUS HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 706 MAURITIUS ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 707 MAURITIUS BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 708 MAURITIUS BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 709 MAURITIUS FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 710 MAURITIUS FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 711 MAURITIUS AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 712 MAURITIUS AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 713 MAURITIUS RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 714 MAURITIUS RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 715 MAURITIUS ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 716 MAURITIUS HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 717 MAURITIUS CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 718 MAURITIUS OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 719 MAURITIUS ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 720 ESWATINI ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 721 ESWATINI HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 722 ESWATINI HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 723 ESWATINI ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 724 ESWATINI BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 725 ESWATINI BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 726 ESWATINI FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 727 ESWATINI FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 728 ESWATINI AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 729 ESWATINI AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 730 ESWATINI RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 731 ESWATINI RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 732 ESWATINI ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 733 ESWATINI HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 734 ESWATINI CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 735 ESWATINI OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 736 ESWATINI ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 737 COMOROS ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 738 COMOROS HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 739 COMOROS HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 740 COMOROS ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 741 COMOROS BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 742 COMOROS BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 743 COMOROS FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 744 COMOROS FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 745 COMOROS AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 746 COMOROS AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 747 COMOROS RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 748 COMOROS RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 749 COMOROS ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 750 COMOROS HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 751 COMOROS CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 752 COMOROS OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 753 COMOROS ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 754 SEYCHELLES ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 755 SEYCHELLES HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 756 SEYCHELLES HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 757 SEYCHELLES ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 758 SEYCHELLES BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 759 SEYCHELLES BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 760 SEYCHELLES FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 761 SEYCHELLES FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 762 SEYCHELLES AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 763 SEYCHELLES AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 764 SEYCHELLES RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 765 SEYCHELLES RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 766 SEYCHELLES ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 767 SEYCHELLES HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 768 SEYCHELLES CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 769 SEYCHELLES OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 770 SEYCHELLES ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 771 REST OF AFRICA ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)